Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: The MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation with Cardiac Resynchronization Therapy)

Journal of the American College of Cardiology

Volumn 62, Issue 15, 2013, Pages 1343-1350

  Ruwald, Martin H ^a,b   Abu Zeitone, Abeer ^a   Jons, Christian ^b   Ruwald, Anne Christine ^a,b   McNitt, Scott ^a   Kutyifa, Valentina ^a   Zareba, Wojciech ^a   Moss, Arthur J ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

Author keywords

beta blockers; defibrillator; heart failure; inappropriate therapy

Indexed keywords

ATENOLOL; BISOPROLOL; CARVEDILOL; METOPROLOL;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; ELECTRIC SHOCK; ELECTROSTIMULATION THERAPY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK REDUCTION; SUPRAVENTRICULAR TACHYCARDIA; THERAPEUTIC ERROR; TREATMENT DURATION;

ANTITACHYCARDIA PACING; ATP; BETA-BLOCKERS; CARDIAC RESYNCHRONIZATION THERAPY WITH DEFIBRILLATOR; CI; CONFIDENCE INTERVAL; CRT-D; DEFIBRILLATOR; HAZARD RATIO; HEART FAILURE; HR; ICD; IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; INAPPROPRIATE THERAPY;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; AGED; ATRIAL FIBRILLATION; CARBAZOLES; CARDIAC RESYNCHRONIZATION THERAPY; COMBINED MODALITY THERAPY; DEFIBRILLATORS, IMPLANTABLE; FEMALE; HEART FAILURE; HUMANS; MALE; METOPROLOL; MULTIVARIATE ANALYSIS; PROPANOLAMINES; REGRESSION ANALYSIS;

EID: 84885008332     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.03.087     Document Type: Article

References (24)

1. E.B. Schron, D.V. Exner, and Q. Yao Quality of life in the antiarrhythmics versus implantable defibrillators trial: impact of therapy and influence of adverse symptoms and defibrillator shocks Circulation 105 2002 589 594
2. J.E. Poole, G.W. Johnson, and A.S. Hellkamp Prognostic importance of defibrillator shocks in patients with heart failure N Engl J Med 359 2008 1009 1017
3. J.P. Daubert, W. Zareba, and D.S. Cannom Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact J Am Coll Cardiol 51 2008 1357 1365
4. K.A. Ellenbogen, J.H. Levine, and R.D. Berger Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy? Circulation 113 2006 776 782
5. J. Irvine, P. Dorian, and B. Baker Quality of life in the Canadian Implantable Defibrillator study (CIDS) Am Heart J 144 2002 282 289
6. J.B. van Rees, C.J. Borleffs, and M.K. de Bie Inappropriate implantable cardioverter-defibrillator shocks: incidence, predictors, and impact on mortality J Am Coll Cardiol 57 2011 556 562
7. A.J. Moss, C. Schuger, and C.A. Beck Reduction in inappropriate therapy and mortality through ICD programming N Engl J Med 367 2012 2275 2283
8. M. Metra, R. Giubbini, and S. Nodari Differential effects of beta-blockers in patients with heart failure: a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol Circulation 102 2000 546 551
9. M.H. Ruwald, A.C. Ruwald, and C. Jons Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy) J Am Coll Cardiol 61 2013 1518 1526
10. P.A. Poole-Wilson, K. Swedberg, and J.G. Cleland Comparison of carvedilol and metoprolol on clinical outcomes in patients with Chronic Heart Failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 2003 7 13
11. J.J. Dinicolantonio, C.J. Lavie, H. Fares, A.R. Menezes, and J.H. O'Keefe Meta-analysis of carvedilol versus beta 1 selective beta-blockers (atenolol, bisoprolol, metoprolol, and nebivolol) Am J Cardiol 111 2013 765 769
12. A.J. Moss, W.J. Hall, and D.S. Cannom Cardiac-resynchronization therapy for the prevention of heart-failure events N Engl J Med 361 2009 1329 1338
13. A.J. Moss, M.W. Brown, and D.S. Cannom Multicenter Automatic Defibrillator Implantation Trial - Cardiac Resynchronization Therapy (MADIT-CRT): design and clinical protocol Ann Noninvasive Electrocardiol 10 2005 34 43
14. A.E. Epstein, J.P. Dimarco, and K.A. Ellenbogen ACC/AHA/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities J Am Coll Cardiol 51 2008 e1 e62
15. J.H. Yang, K. Byeon, and H.R. Yim Predictors and clinical impact of inappropriate implantable cardioverter-defibrillator shocks in Korean patients J Korean Med Sci 27 2012 619 624
16. S.P. Bhavnani, C.I. Coleman, and C.M. White Association between statin therapy and reductions in atrial fibrillation or flutter and inappropriate shock therapy Europace 10 2008 854 859
17. H. Desai, W.S. Aronow, and C. Ahn Risk factors for appropriate cardioverter-defibrillator shocks, inappropriate cardioverter-defibrillator shocks, and time to mortality in 549 patients with heart failure Am J Cardiol 105 2010 1336 1338
18. W.N. Brodine, R.T. Tung, and J.K. Lee Effects of beta-blockers on implantable cardioverter defibrillator therapy and survival in the patients with ischemic cardiomyopathy (from the Multicenter Automatic Defibrillator Implantation Trial-II) Am J Cardiol 96 2005 691 695
19. G.C. Fonarow, W.T. Abraham, and N.M. Albert Dosing of beta-blocker therapy before, during, and after hospitalization for heart failure (from organized program to initiate lifesaving treatment in hospitalized patients with heart failure) Am J Cardiol 102 2008 1524 1529
20. F.A. McAlister, N. Wiebe, J.A. Ezekowitz, A.A. Leung, and P.W. Armstrong Meta-analysis: beta-blocker dose, heart rate reduction, and death in patients with heart failure Ann Intern Med 150 2009 784 794
21. S.J. Connolly, P. Dorian, and R.S. Roberts Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC study: a randomized trial JAMA 295 2006 165 171
22. E.M. Gilbert, W.T. Abraham, and S. Olsen Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart Circulation 94 1996 2817 2825
23. J.E. Sanderson, S.K. Chan, and G. Yip Beta-blockade in heart failure: a comparison of carvedilol with metoprolol J Am Coll Cardiol 34 1999 1522 1528
24. M. Packer, G.V. Antonopoulos, and J.A. Berlin Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis Am Heart J 141 2001 899 907